Inovio Pharmaceuticals, Inc.INONASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+561.1%
5Y CAGR+256.4%
Year-over-Year Change
Research and development spending
3Y CAGR
+561.1%/yr
vs +18.5%/yr prior
5Y CAGR
+256.4%/yr
Recent acceleration
Acceleration
+542.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
575.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $54.21B | +71582.9% |
| 2024 | $75.62M | -12.8% |
| 2023 | $86.68M | -53.8% |
| 2022 | $187.65M | -24.7% |
| 2021 | $249.24M | +164.5% |
| 2020 | $94.25M | +7.1% |
| 2019 | $88.02M | -7.6% |
| 2018 | $95.26M | -3.4% |
| 2017 | $98.57M | +11.1% |
| 2016 | $88.71M | - |